Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    John Newman, MD, PhD

    TitleAssistant Professor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1650 Owens St
    San Francisco CA 94107
    Phone415-502-5134
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Yale UniversityBS/MSMolecular Biophysics and Biochemistry2000
      University of WashingtonMD/PhDBiochemistry2008
      UCSFResidencyInternal Medicine2010
      UCSFFellowshipGeriatric Medicine2011
      Collapse Awards and Honors
      National Institute on Aging and American Federation for Aging Research2014 - 2019Beeson Scholar
      Larry L. Hillblom Foundation2012 - 2015Postdoctoral Fellowship
      Larry L. Hillblom Foundation2014John S. Spice Award in Aging
      Paul F. Glenn Foundation2013Glenn Award for Research in Biological Mechanisms of Aging
      Gladstone Institute of Virology and Immunology2013Award of Excellence in Scientific Leadership
      John A. Hartford Foundation2011 - 2013Hartford Scholar

      Collapse Overview 
      Collapse Overview
      Dr. Newman is a geriatrician, basic science researcher, and educator in the Division of Geriatrics at UCSF. As a physician-scientist, Dr. Newman hopes to translate what we are learning of the pathways that control fundamental mechanisms of aging into therapies that will improve the health and preserve the independence of older adults.

      His research work is in the laboratory of Eric Verdin at the Gladstone Institutes, and focuses on how ketone bodies, small molecules that our bodies make for energy when we fast or exercise, also act as molecular signals to control inflammation and gene expression. The signaling functions of ketone bodies may be translational targets for protecting cognition and improving resilience in older adults. This is one example how environmental cues like diet and fasting signal through small metabolites in our cells to regulate the genes and pathways that in turn control aging. Dr. Newman is particularly interested in testing if harnessing these signals can protect older adults from the risks of hospitalization like delirium and functional decline.

      Dr. Newman attends on the inpatient medicine service and the acute care of elders unit at the San Francisco VA Medical Center, with a clinical focus on delirium and functional decline. He teaches students, residents, and fellows about geriatric clinical problems, as well as about the biology of aging and emerging translational science in geriatrics. He works as a part of the national Geroscience Network to develop frameworks and resources for testing interventions that target fundamental mechanisms of aging in clinical trials. He seeks to bridge the community of basic scientists that study aging to geriatricians and other clinicians who study the clinical problems of aging in order to develop innovative translational therapies.

      Dr. Newman completed an MD/PhD at the University of Washington in Seattle, then residency training in Internal Medicine and a fellowship in Geriatrics at UCSF before joining the faculty in 2014. Dr. Newman is a 2014 Beeson Scholar from the National Institute on Aging and the American Federation of Aging Research. His work has also been supported by generous funding from the Larry L. Hillblom Foundation and the Glenn Foundation for Medical Research.

      Assistant Professor, Division of Geriatrics at UCSF
      Visiting Scientist, Gladstone Institutes
      Geriatrician, San Francisco VA Medical Center

      Collapse Interests
      Geriatrics, aging, acute care of elders, frailty, longevity, metabolism, dietary restriction, ketone bodies, gene expression, epigenetics

      Collapse ORNG Applications 
      Collapse Awarded Grants
      Collapse Twitter
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Newman JC, Milman S, Hashmi SK, Austad SN, Kirkland JL, Halter JB, Barzilai N, et al. Strategies and Challenges in Clinical Trials Targeting Human Aging. J Gerontol A Biol Sci Med Sci. 2016 Aug 16. PMID: 27535968.
        View in: PubMed
      2. Justice J, Miller JD, Newman JC, Hashmi SK, Halter J, Austad SN, Barzilai N, Kirkland JL, et al. Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes. J Gerontol A Biol Sci Med Sci. 2016 Aug 16. PMID: 27535966.
        View in: PubMed
      3. Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E. Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. Elife. 2016; 5. PMID: 27244239.
        View in: PubMed
      4. Newman JC. Copyright and Bedside Cognitive Testing: Why We Need Alternatives to the Mini-Mental State Examination. JAMA Intern Med. 2015 Sep; 175(9):1459-60. PMID: 26053392.
        View in: PubMed
      5. Newman JC, Verdin E. ß-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract. 2014 Nov; 106(2):173-81. PMID: 25193333; PMCID: PMC4414487.
      6. Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, Danielson SR, Guo A, Gut P, Sahu AK, Li B, Uppala R, Fitch M, Riiff T, Zhu L, Zhou J, Mulhern D, Stevens RD, Ilkayeva OR, Newgard CB, Jacobson MP, Hellerstein M, Goetzman ES, Gibson BW, Verdin E. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 2013 Dec 3; 18(6):920-33. PMID: 24315375; PMCID: PMC4105152.
      7. Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014 Jan; 25(1):42-52. PMID: 24140022; PMCID: PMC4176946.
      8. Yee P, Newman J. Long-term outcomes in elderly survivors of cardiac arrest. N Engl J Med. 2013 Jun 20; 368(25):2438. PMID: 23782194.
        View in: PubMed
      9. Rardin MJ, Newman JC, Held JM, Cusack MP, Sorensen DJ, Li B, Schilling B, Mooney SD, Kahn CR, Verdin E, Gibson BW. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc Natl Acad Sci U S A. 2013 Apr 16; 110(16):6601-6. PMID: 23576753; PMCID: PMC3631688.
      10. Feldman R, Newman J. . Copyright at the Bedside: Should We Stop the Spread?. Stanford Technology Law Review. 2013; 16(3):623.
      11. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV, de Cabo R, Ulrich S, Akassoglou K, Verdin E. Suppression of oxidative stress by ß-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013 Jan 11; 339(6116):211-4. PMID: 23223453; PMCID: PMC3735349.
      12. Newman JC, He W, Verdin E. Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J Biol Chem. 2012 Dec 14; 287(51):42436-43. PMID: 23086951; PMCID: PMC3522244.
      13. He W, Newman JC, Wang MZ, Ho L, Verdin E. Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol Metab. 2012 Sep; 23(9):467-76. PMID: 22902903.
        View in: PubMed
      14. Bailey AD, Gray LT, Pavelitz T, Newman JC, Horibata K, Tanaka K, Weiner AM. The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells. DNA Repair (Amst). 2012 May 1; 11(5):488-501. PMID: 22483866; PMCID: PMC3340519.
      15. Newman JC, Feldman R. Copyright and open access at the bedside. N Engl J Med. 2011 Dec 29; 365(26):2447-9. PMID: 22204721.
        View in: PubMed
      16. Frederick M, Newman J, Kohlwes J. Leriche syndrome. J Gen Intern Med. 2010 Oct; 25(10):1102-4. PMID: 20568019; PMCID: PMC2955474.
      17. Newman JC, Bailey AD, Fan HY, Pavelitz T, Weiner AM. An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. PLoS Genet. 2008 Mar; 4(3):e1000031. PMID: 18369450; PMCID: PMC2268245.
      18. Cahan P, Rovegno F, Mooney D, Newman JC, St Laurent G, McCaffrey TA. Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. Gene. 2007 Oct 15; 401(1-2):12-8. PMID: 17651921; PMCID: PMC2111172.
      19. Newman JC, Bailey AD, Weiner AM. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc Natl Acad Sci U S A. 2006 Jun 20; 103(25):9613-8. PMID: 16772382; PMCID: PMC1480455.
      20. Newman JC, Weiner AM. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol. 2005; 6(9):R81. PMID: 16168088; PMCID: PMC1242216.
      21. Newman JC, Weiner A. Measuring the immeasurable. Mol Cell. 2002 Sep; 10(3):437-9. PMID: 12408812.
        View in: PubMed
      22. Schutzman JL, Borland CZ, Newman JC, Robinson MK, Kokel M, Stern MJ. The Caenorhabditis elegans EGL-15 signaling pathway implicates a DOS-like multisubstrate adaptor protein in fibroblast growth factor signal transduction. Mol Cell Biol. 2001 Dec; 21(23):8104-16. PMID: 11689700; PMCID: PMC99976.
      John's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP